Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-19

Clinical Trial Update: The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

View source ↗

Summary

A clinical trial evaluating whether albumin/globulin ratio and platelet/albumin ratio serve as biomarkers in Lupus Nephritis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Lupus Nephritis (LN), SLE - Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING